Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

被引：38

作者：

Rossi, Ernesto ^{[1
]}

Schinzari, Giovanni ^{[1
,2
]}

Zizzari, Ilaria Grazia ^{[3
]}

Maiorano, Brigida Anna ^{[1
]}

Pagliara, Monica Maria ^{[4
]}

Sammarco, Maria Grazia ^{[4
]}

Fiorentino, Vincenzo ^{[5
]}

Petrone, Gianluigi ^{[5
]}

Cassano, Alessandra ^{[1
,2
]}

Rindi, Guido ^{[5
]}

Bria, Emilio ^{[1
,2
]}

Blasi, Maria Antonietta ^{[4
]}

Nuti, Marianna ^{[3
]}

Tortora, Giampaolo ^{[1
,2
]}

机构：

[1] Fdn Policlin Univ, A Gemelli IRCCS, Med Oncol, I-00168 Rome, Italy

[2] Univ Cattolica Sacro Cuore, Med Oncol, I-00168 Rome, Italy

[3] Sapienza Univ, Dept Expt Med, Lab Tumor Immunol & Cell Therapy, Policlin Umberto 1, I-00162 Rome, Italy

[4] Fdn Policlin Univ, A Gemelli IRCCS, Ophtalmol, I-00168 Rome, Italy

[5] Fdn Policlin Univ, A Gemelli IRCCS, Pathol, I-00168 Rome, Italy

来源：

CANCERS | 2019年 / 11卷 / 08期

关键词：

immunotherapy; uveal melanoma; checkpoint inhibitors; PD-L1; nivolumab; pembrolizumab; ipilimumab; IDO; TUMOR-INFILTRATING LYMPHOCYTES; MIGRATION-INHIBITORY FACTOR; CANDIDATE PROTEINS GP100; ANTIGEN EXPRESSION; ADOPTIVE TRANSFER; HLA EXPRESSION; CELL-ACTIVITY; MONOSOMY; CLASS-I; IPILIMUMAB;

D O I：

10.3390/cancers11081055

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immunotherapy. The immunological features of mUM were reviewed in order to understand if immunotherapy could still play a role for this disease.

引用

页数：12

共 50 条

[21] Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Leonard-Murali, Shravan
Bhaskarla, Chetana
Yadav, Ghanshyam S.
Maurya, Sudeep K.
Galiveti, Chenna R.
Tobin, Joshua A.
Kann, Rachel J.
Ashwat, Eishan
Murphy, Patrick S.
Chakka, Anish B.
Soman, Vishal
Cantalupo, Paul G.
Zhuo, Xinming
Vyas, Gopi
Kozak, Dara L.
Kelly, Lindsey M.
Smith, Ed
Chandran, Uma R.
Hsu, Yen-Michael S.
Kammula, Udai S.
NATURE COMMUNICATIONS, 2024, 15 (01)
[22] Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies
Kimberly M. Komatsubara
Richard D. Carvajal
Current Oncology Reports, 2017, 19
[23] New immunotherapy approaches as the most effective treatment for uveal melanoma
Eteghadi, Atefeh
Ebrahimi, Maryam
Keshel, Saeed Heidari
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 194
[24] Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies
Komatsubara, Kimberly M.
Carvajal, Richard D.
CURRENT ONCOLOGY REPORTS, 2017, 19 (07)
[25] How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
Marseglia, Mariarosaria
Amaro, Adriana
Solari, Nicola
Gangemi, Rosaria
Croce, Elena
Tanda, Enrica Teresa
Spagnolo, Francesco
Filaci, Gilberto
Pfeffer, Ulrich
Croce, Michela
CANCERS, 2021, 13 (09)
[26] Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment
Masaoutis, Christos
Kokkali, Stefania
Theocharis, Stamatios
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (05) : 555 - 569
[27] Immunotherapy Cul-TIL-vating uveal melanoma regression
Hutchinson, Lisa
NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (06) : 328 - 329
[28] Vaccination with dendritic Cells for metastasized Uveal Melanoma: immunological and clinical Responses
Moreira, A.
Gross, S.
Uslu, U.
Doerrie, J.
Kummer, M.
Schliep, S.
Sponagl, F.
Lischer, C.
Erdmann, M.
Heinzerling, L.
Schuler, G.
Schuler-Thurner, B.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 18 - 19
[29] HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target
Souri, Zahra
Wierenga, Annemijn P. A.
Mulder, Arend
Jochemsen, Aart G.
Jager, Martine J.
CANCERS, 2019, 11 (08)
[30] Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis
Pan, Hui
Lu, Linna
Cui, Junqi
Yang, Yuan
Wang, Zhaoyang
Fan, Xianqun
AGING-US, 2020, 12 (02): : 1446 - 1464

← 1 2 3 4 5 →